Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-002351

Options or other derivatives

  • Chief Medical Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-04 Grant or award : show line 1 in the form Restricted Stock Units +30,000 30,000 D
2021-01-04 Grant or award : show line 2 in the form Stock Option (right to buy) +90,000 90,000 D
Loading xslF345X03/doc4.xml…